Journal article
Does bacillus Calmette-Guérin vaccine prevent herpes simplex virus recurrences? A systematic review
LF Pittet, N Curtis
Reviews in Medical Virology | WILEY | Published : 2021
DOI: 10.1002/rmv.2151
Abstract
Recurrent infections with herpes simplex virus (HSV) in the orofacial (cold sores), ocular or genital region are common and sometimes disabling, calling for an effective preventive intervention. The bacillus Calmette-Guérin (BCG) vaccine has beneficial off-target effects that might impact recurrence of HSV infections. In this systematic review, Medline, EMBASE, and PubMed were searched in June 2020; 16 articles were deemed relevant comprising eight animal and eight human studies (301 patients). In animals, BCG administration led to a 1.9 to 5.5-fold increase in survival rate following HSV challenge (vaginal, corneal, or intraperitoneal inoculation). This beneficial effect was influenced by t..
View full abstractGrants
Awarded by Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Funding Acknowledgements
Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung, Grant/Award Number: Early Postdoc.Mobility grant number P2GEP3_178155